Following positive research findings , retatrutide, a innovative peptide therapy for addressing adult-onset diabetes , has received regulatory approval from the Medicines and Products Agency ( MHRA https://lillioikb014955.prublogger.com/40116910/retatrutide-medication-peptide-uk-approval-and-launch